Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Inflammatory and Nutritional Serum Markers as Predictors of Peri-operative Morbidity and Survival in Ovarian Cancer.

Kumar A, Torres ML, Cliby WA, Kalli KR, Bogani G, Aletti G, Nitschmann CC, Multinu F, Weaver AL, Block MS, Mariani A.

Anticancer Res. 2017 Jul;37(7):3673-3677.

PMID:
28668859
2.

Vaginal vs. robotic hysterectomy for patients with endometrial cancer: A comparison of outcomes and cost of care.

Nitschmann CC, Multinu F, Bakkum-Gamez JN, Langstraat CL, Occhino JA, Weaver AL, Cliby WA, Mariani A, Dowdy SC.

Gynecol Oncol. 2017 Jun;145(3):555-561. doi: 10.1016/j.ygyno.2017.03.002. Epub 2017 Apr 6.

PMID:
28392125
3.

A prospective algorithm to reduce anastomotic leaks after rectosigmoid resection for gynecologic malignancies.

Kalogera E, Nitschmann CC, Dowdy SC, Cliby WA, Langstraat CL.

Gynecol Oncol. 2017 Feb;144(2):343-347. doi: 10.1016/j.ygyno.2016.11.032. Epub 2016 Dec 2.

PMID:
27919575
4.

Preoperative leukocytosis imposes an increased risk of recurrence and death among patients with nonendometrioid endometrial carcinoma.

Worley MJ Jr, Nitschmann CC, Shoni M, Rauh-Hain JA, Williams KA, Feltmate CM.

Int J Gynecol Cancer. 2013 Feb;23(2):312-7. doi: 10.1097/IGC.0b013e31827da21b.

PMID:
23358179
5.

Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma.

Rauh-Hain JA, Nitschmann CC, Worley MJ Jr, Bradford LS, Berkowitz RS, Schorge JO, Campos SM, del Carmen MG, Horowitz NS.

Gynecol Oncol. 2013 Apr;129(1):63-8. doi: 10.1016/j.ygyno.2013.01.009. Epub 2013 Jan 18.

PMID:
23337490
6.

The significance of preoperative leukocytosis in endometrial carcinoma.

Worley MJ Jr, Nitschmann CC, Shoni M, Vitonis AF, Rauh-Hain JA, Feltmate CM.

Gynecol Oncol. 2012 Jun;125(3):561-5. doi: 10.1016/j.ygyno.2012.03.043. Epub 2012 Mar 29.

PMID:
22465698

Supplemental Content

Loading ...
Support Center